IL149007A0 - Pentacyclic taxane compounds - Google Patents

Pentacyclic taxane compounds

Info

Publication number
IL149007A0
IL149007A0 IL14900700A IL14900700A IL149007A0 IL 149007 A0 IL149007 A0 IL 149007A0 IL 14900700 A IL14900700 A IL 14900700A IL 14900700 A IL14900700 A IL 14900700A IL 149007 A0 IL149007 A0 IL 149007A0
Authority
IL
Israel
Prior art keywords
taxane compounds
pentacyclic taxane
pentacyclic
compounds
taxane
Prior art date
Application number
IL14900700A
Other languages
English (en)
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of IL149007A0 publication Critical patent/IL149007A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4355Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
IL14900700A 1999-10-15 2000-10-12 Pentacyclic taxane compounds IL149007A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29335699 1999-10-15
PCT/JP2000/007087 WO2001027115A1 (fr) 1999-10-15 2000-10-12 Composes pentacycliques au taxane

Publications (1)

Publication Number Publication Date
IL149007A0 true IL149007A0 (en) 2002-11-10

Family

ID=17793741

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14900700A IL149007A0 (en) 1999-10-15 2000-10-12 Pentacyclic taxane compounds
IL149007A IL149007A (en) 1999-10-15 2002-04-04 Pentaxic compounds, their preparation and intermediates

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL149007A IL149007A (en) 1999-10-15 2002-04-04 Pentaxic compounds, their preparation and intermediates

Country Status (22)

Country Link
EP (1) EP1221445B1 (xx)
JP (1) JP3776799B2 (xx)
KR (1) KR100706566B1 (xx)
CN (1) CN1203074C (xx)
AR (1) AR026026A1 (xx)
AT (1) ATE405569T1 (xx)
AU (1) AU774787B2 (xx)
BR (1) BR0014687A (xx)
CA (1) CA2386772C (xx)
DE (1) DE60039998D1 (xx)
DK (1) DK1221445T3 (xx)
ES (1) ES2311473T3 (xx)
HK (1) HK1044000B (xx)
IL (2) IL149007A0 (xx)
MX (1) MXPA02003797A (xx)
MY (1) MY125378A (xx)
NO (1) NO328418B1 (xx)
PT (1) PT1221445E (xx)
RU (1) RU2257387C2 (xx)
TW (1) TWI225062B (xx)
WO (1) WO2001027115A1 (xx)
ZA (1) ZA200202696B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100886805B1 (ko) * 2001-11-29 2009-03-05 다이이찌 세이야꾸 가부시기가이샤 탁산 유도체 결정 및 그 제조방법
TW200533339A (en) 2004-03-16 2005-10-16 Bristol Myers Squibb Co Therapeutic synergy of anti-cancer compounds
JP4800205B2 (ja) * 2004-04-30 2011-10-26 第一三共株式会社 五環性タキサンの製造方法
JPWO2007049575A1 (ja) * 2005-10-25 2009-04-30 第一三共株式会社 アゼチジン環構造を有するタキサン化合物
CN100516067C (zh) * 2006-01-10 2009-07-22 上海恒瑞医药有限公司 具有抗肿瘤活性的紫杉酚衍生物
US8785669B2 (en) 2010-06-30 2014-07-22 Gfv, Llc Taxane compounds, compositions and methods
KR20140056238A (ko) 2011-08-02 2014-05-09 아스텔라스세이야쿠 가부시키가이샤 약제의 병용에 의한 암 치료 방법
FR2986526A1 (fr) 2012-02-03 2013-08-09 Sanofi Sa Procede de preparation de derives du taxol et certains composes intermediaires
CN104650109B (zh) * 2013-11-22 2019-01-01 江苏天士力帝益药业有限公司 紫杉烷类化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2712289B1 (fr) * 1993-11-08 1996-01-05 Rhone Poulenc Rorer Sa Nouveaux dérivés de taxicine, leur préparation et les compositions pharmaceutiques qui les contiennent.
EP0826688B1 (en) * 1995-04-28 2001-09-05 Daiichi Pharmaceutical Co., Ltd. Pentacyclic compounds
TW527183B (en) * 1996-06-06 2003-04-11 Daiichi Seiyaku Co Drug complex

Also Published As

Publication number Publication date
NO20021753D0 (no) 2002-04-12
CA2386772A1 (en) 2001-04-19
HK1044000A1 (en) 2002-10-04
EP1221445B1 (en) 2008-08-20
EP1221445A4 (en) 2003-05-28
RU2257387C2 (ru) 2005-07-27
DK1221445T3 (da) 2008-11-24
AU7685100A (en) 2001-04-23
JP3776799B2 (ja) 2006-05-17
ATE405569T1 (de) 2008-09-15
TWI225062B (en) 2004-12-11
AR026026A1 (es) 2002-12-26
KR20020035901A (ko) 2002-05-15
EP1221445A1 (en) 2002-07-10
AU774787B2 (en) 2004-07-08
NO20021753L (no) 2002-06-12
NO328418B1 (no) 2010-02-15
MY125378A (en) 2006-07-31
CN1409714A (zh) 2003-04-09
MXPA02003797A (es) 2002-12-13
WO2001027115A1 (fr) 2001-04-19
CA2386772C (en) 2009-01-13
PT1221445E (pt) 2008-10-08
HK1044000B (zh) 2008-11-21
CN1203074C (zh) 2005-05-25
DE60039998D1 (de) 2008-10-02
ZA200202696B (en) 2003-09-23
ES2311473T3 (es) 2009-02-16
KR100706566B1 (ko) 2007-04-13
IL149007A (en) 2006-12-10
BR0014687A (pt) 2002-11-19

Similar Documents

Publication Publication Date Title
GB2357761B (en) Compounds
GB9904933D0 (en) Compounds
IL149007A0 (en) Pentacyclic taxane compounds
GB9908828D0 (en) Compounds
GB9902399D0 (en) Compounds
GB9904930D0 (en) Thiazoloindolinone compounds
GB9914821D0 (en) Compounds
GB9905771D0 (en) Compounds
GB9916647D0 (en) Compounds
GB9914363D0 (en) Take note
GB9903266D0 (en) Compounds
GB9906278D0 (en) Compounds
GB9903271D0 (en) Compounds
GB9903269D0 (en) Compounds
GB9909802D0 (en) Compounds
GB9909474D0 (en) Compounds
GB9908931D0 (en) Compounds
GB9913821D0 (en) Compounds
GB9903268D0 (en) Compounds
GB9913823D0 (en) Compounds
GB9909839D0 (en) Compounds
GB9903243D0 (en) Compounds
GB9910711D0 (en) Compounds
GB9903239D0 (en) Compounds
GB9907456D0 (en) Compounds

Legal Events

Date Code Title Description
KB Patent renewed
FF Patent granted